Why the study?
Does lung-endothelium-specific angiopoietin-2 small interfering RNA improve survival and reduce organ dysfunction in a murine model of sepsis?
Does lung-endothelium-specific angiopoietin-2 small interfering RNA improve survival and reduce organ dysfunction in a murine model of sepsis?
Lung-targeted RNA interference against angiopoietin-2 ameliorates multiple organ dysfunction and improves survival in a murine model of sepsis.
Answers are grounded in this paper and cite their sources.
Does not support clinical use in sepsis; leaves open human translation of lung-targeted angiopoietin-2 siRNA.
Objective Angiopoietin-2, a protein secreted by stimulated endothelium and an antagonist of the endothelium-stabilizing receptor Tie2, contributes to the pathophysiology of septic multiple organ dysfunction. We tested the therapeutic potential of a pulmonary-endothelium-specific RNA interference-based angiopoietin-2 targeting strategy in sepsis. Design Laboratory and animal research. Settings Research laboratories of the Medical School Hannover, Department of Nephrology and Hypertension, Hannover and Silence Therapeutics GmbH, Berlin. Subjects C57Bl/6 mice. Interventions Lung-endothelium-specific angiopoietin-2 small interfering RNA was administered both before and after sepsis induction (cecal ligation and puncture or lipopolysaccharides) intravenously. Measurements and main results Angiopoietin-2 small interfering RNA was highly specific and reduced angiopoietin-2 expression in the septic murine lungs up to 73.8% (p = 0.01) and enhanced the phosphorylation of Tie2 both in control and septic animals. Angiopoietin-2 small interfering RNA reduced pulmonary interleukin-6 transcription, intercellular adhesion molecule expression, neutrophil infiltration, and vascular leakage. Manifestations of sepsis were also attenuated in distant organs, including the kidney, where renal function was improved without affecting local angiopoietin-2 production. Finally, angiopoietin-2 small interfering RNA ameliorated the severity of illness and improved survival in cecal ligation and puncture, both as a pretreatment and as a rescue intervention. Conclusion The Tie2 antagonist angiopoietin-2 represents a promising target against sepsis-associated multiple organ dysfunction. A novel RNA interference therapeutic approach targeting gene expression in the pulmonary endothelium could be a clinically relevant pharmacological strategy to reduce injurious angiopoietin-2 synthesis.
No takes yet. Share an insight, caveat, or question.
Stiehl et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: